Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19: GlobalData Read more
To accelerate recovery of pharma ancillary industry, primary focus should be financial relief to players Read more
67 per cent experts to use decentralised clinical trials in near future due to COVID-19: GlobalData Read more